About Alan Walts
Alan Walts is a director at Artax Biopharma.
Alan Walts first appears on SEC filings in 2019.
Experience
This experience comes from Alan Walts's profile and from SEC filings. For roles taken from filings, the years are when the filings name Alan Walts in the role, so the role may have started earlier or lasted longer.
AB
Aleta Biotherapeutics Current
Chief Executive Officer
2025 – Present
AT
AlphaRose Therapeutics Current
Co-founder and Executive Chairman
2024 – Present
EP
Eloxx Pharmaceuticals Current
Chairman
2021 – Present
HP
Hemogenyx Pharmaceuticals Current
Advisor and Board Observer
2021 – Present
TI
Termeer Institute Current
Board Member and Treasurer
2019 – Present
AF
ALS Investment Fund Current
Advisory Board Member
2018 – Present
Artax Biopharma, Inc. Current
Director
2017 – Present · Cambridge, MA
Develops oral drug candidates for people with autoimmune diseases.
TE
Termeer Estate Current
Business Advisor
2017 – Present
PT
PIC Therapeutics Current
Board Member
2016 – Present
NE
Neuroelectrics Current
Board Member
2015 – Present
AT
Arrakis Therapeutics Current
Board Observer
2015 – Present
AL
Advent Life Sciences LLP Current
Venture Partner
2014 – Present
ZT
Zikani Therapeutics
Executive Chairman
2019 – 2021
AB
Aura Biosciences
Board Observer
2013 – 2021
AP
Amylyx Pharmaceuticals
Board Observer
2017 – 2020
XP
X4 Pharmaceuticals
Founder and Board Member
2015 – 2019
HT
Henri Termeer
Business Advisor
2013 – 2017
GE
Genzyme
Senior Advisor & Senior Vice President, Sanofi-Genzyme BioVentures
2001 – 2013
Key Colleagues at Startups
The people Alan Walts works with at each company, as listed on that company's latest Form D.
Artax Biopharma, Inc. · Form D/A, May 5, 2026
Joe Suarez
Chief Financial Officer
Andre Hoekema
Board Chair
Maria Nichol
Chief Business Officer
DD
Damia Tormo, Ph.D.
Director
GS
Gino Santini
Director
Casper Breum
Director
RP
Raj Parekh
Director
Robert Armstrong, Ph.D.
Chief Executive Officer and director